Most people who ask about hormone replacement therapy are not looking for a miracle, they want their life back. They want to sleep through the night, stop snapping at their partner, feel some spark in the gym or in bed, and recognize themselves in the mirror. In our clinic, I have seen a school principal regain steady focus after months of brain fog, a welder return to his early shift without a 2 pm crash, and a runner in perimenopause stop feeling ambushed by hot flashes on mile three. The common thread was not an exotic drug. It was the right hormone, at the right dose, in the right form, monitored with care.
Compounded hormone therapy sits in the middle of that conversation. It is not for everyone, and it is not a carte blanche to “biohack” with hormones. When it is chosen for the right reasons, it can solve a very practical problem that off-the-shelf products cannot: custom dosing for unique physiology.
What “compounded” really means
Compounding is the process of preparing a medication tailored to an individual prescription. A licensed pharmacist blends raw active ingredients into a customized dosage form, such as a low-dose sustained-release capsule, a precise transdermal cream concentration, or a troche that dissolves in the cheek. For hormone therapy the actives are often bioidentical hormones like estradiol, progesterone, and testosterone that share the same molecular structure as endogenous hormones. Those molecules are also present in many FDA-approved products. The difference is that a compound can be made at a dose or in a combination that does not exist commercially.
That is the critical distinction. Compounded hormone therapy is not a synonym for “natural hormone therapy,” and it is not required to get bioidentical hormones. Many people do very well with approved estradiol patches or micronized progesterone capsules. Other people do not, because they are sensitive to an adhesive, need a lower dose than the smallest patch, or require a ratio of hormones that is outside the standard choices. Compounding was built for those margins.
Where compounded therapy can add value
Two situations show up again and again in practice. First, someone cannot tolerate a commercially available product. A patient might develop a rash to a specific patch adhesive, headaches from a fixed-dose combination pill, or GI upset from a particular filler. Second, standard doses overshoot or undershoot. I have women in perimenopause who feel stable on 0.025 mg transdermal estradiol, but the smallest retail patch delivers 0.025 mg only in a brand they cannot tolerate, and the next brand available is 0.0375 mg, which is too stimulating. A compounded cream at 0.02 mg per actuation solves that gap.
The same logic holds for men on testosterone therapy. A topical gel in a set pump might deliver 20.25 mg per pump, which forces big jumps in dose. Some men need 10 to 15 mg daily, and that precision only happens when we can adjust the concentration. Transgender patients navigating gender-affirming hormone therapy often need incremental titration over months to match their bodies’ response, and compounding allows those finer steps without cutting patches or opening capsules.
Compounded formulations can also remove allergens. I have had success avoiding peanut oil, dyes, and certain parabens, which, for a small subset of patients, make all the difference between adherence and abandonment.
What to use, and what to question
The route you choose changes both efficacy and risk. This is where details matter.
Transdermal estradiol has a well-described advantage over oral estrogen in reducing first-pass liver effects. When estradiol bypasses the liver, it does not raise clotting proteins to the same extent, and observational data has consistently associated transdermal estradiol with a lower risk of venous thromboembolism compared with oral estrogen. If a woman has migraine with aura, a family history of clotting disorders, obesity, or is older than 60, I lean hard toward transdermal options. Compounded creams or gels can match the strengths of patches, or fill in between them. When we need ultra-low starts, I will order something like 0.1 mg per gram cream, one pea-sized amount nightly, and step up by 0.05 mg every two weeks based on symptoms and, later, labs.
Micronized progesterone, taken at bedtime, is still my first line for endometrial protection in women with a uterus who use estrogen therapy. The sedation many patients experience can be a gift for those with fragmented sleep. If someone cannot tolerate the standard 100 mg capsule, a compounded slow-release version at 50 or 75 mg may smooth side effects. For women sensitive to oral progesterone, a vaginal route can deliver endometrial protection with less systemic impact, again at doses we can fine tune.
Testosterone therapy deserves careful language. Approved testosterone products are designed for men with unequivocal hypogonadism. Men with true low testosterone often report marked improvements in energy, libido, and body composition on properly dosed testosterone replacement therapy. I have seen a 52-year-old carpenter regain his grip strength and a calmer mood within 8 weeks after moving his morning total testosterone from 240 ng/dL to a stable 550 to 650 ng/dL. But testosterone is not benign. Erythrocytosis, acne, oily skin, snoring that tips into sleep apnea, and shifts in HDL are common trade-offs. Compounding helps when the jump between commercially available doses is too wide, or when a formulation vehicle triggers dermatitis. I never use compounded testosterone to bypass appropriate diagnostic criteria. The lab work, the clinical picture, and the discussion of fertility preservation come first.
Pellet hormone therapy occupies a contested space. Pellets provide a long tail of release, usually 2 to 5 months depending on dose and metabolism. For a motivated patient who travels or struggles with adherence, that convenience is real. I also see problems that are harder to unwind. Once implanted, you cannot lower the dose, and some people are hypersensitive to a high early peak in testosterone or estradiol. I have managed pellet recipients with mood lability, acne flares, and gynecomastia in men when the dose was aggressive. If pellets are chosen, I prefer conservative first implants, meticulous selection of insertion technique to reduce infection risk, and an acknowledgment that dose adjustments will take months.
Troches, buccal tablets, and sublingual drops are popular in compounded bioidentical hormones. They can work, but absorption varies with saliva flow and mucosal integrity, and swallowing the dissolved product effectively turns it into an oral dose with more first-pass metabolism. I generally avoid compounded oral estradiol because of clot risk profiles, favor transdermal estradiol, and reserve troches for particular scenarios like progesterone intolerance or targeted timing needs for sexual function.
Safety, regulation, and the variability question
Two things can be true at once. Compounded therapy meets real needs, and its quality is more variable than factory-made medications. FDA-approved drugs are produced under current good manufacturing practice with batch testing and tight potency specifications. Compounded medications are prepared under standards such as USP <795> for nonsterile compounding and USP <797> for sterile compounding. Good compounding pharmacies run rigorous internal quality checks and may seek accreditation from organizations like PCAB. I work only with pharmacies that provide certificates of analysis on request, use high-grade actives, and demonstrate consistent potency checks.
Even then, independent examinations have found potency deviations in some compounded hormones. Reported ranges vary by study, but think single-digit to low double-digit percentage differences compared to labeled strength. That matters if you rely on 0.2 mg versus 0.3 mg of estradiol to control a patient’s migraines. It also means that when symptoms and labs do not add up, I consider a pharmacy switch rather than simply raising the dose.
A second safety piece concerns marketing claims. “Natural” does not equal safer. Bioidentical does not mean risk free. Endometrial cancer protection still requires adequate progesterone when a woman with a uterus uses estrogen. Breast cancer risk is complex and individual. Long-term cardiovascular outcomes depend on timing, route, and patient baseline risk. Any clinic that prescribes compounded hormones without taking a full history, reviewing medications, and planning lab monitoring is not offering hormone balancing, it is offering a guess.
How I approach evaluation and dosing
Every good HRT plan starts with a story. A rushed visit that jumps straight to a prescription misses patterns that move the needle. I want to know sleep timing, night sweats, menstrual history, migraines, libido, vaginal comfort, weight shifts, bowel habits, mood, and stressors. I ask about pregnancy complications, clotting history, liver disease, thyroid symptoms, and current supplements. I review goals explicitly. Some patients want less rage at 4 pm. Others want to keep powerlifting totals while trimming visceral fat. Those goals affect what I prioritize.
Labs are tools, not oracles. For women near menopause, I focus on symptoms and, depending on the situation, may order FSH, estradiol, and progesterone as anchoring points, but I do not chase monthly fluctuations. For women using HRT, serum estradiol on a stable dose helps me avoid overshooting. For men being evaluated for TRT, I obtain at least two early morning total testosterone levels, with SHBG and free testosterone if the picture is unclear. I screen LH, FSH, prolactin, a complete blood count, fasting lipids, A1c, and, when relevant, iron studies and thyroid function. For transgender hormone therapy, I review baseline risks and set a schedule for titration and monitoring aligned with established gender-affirming care guidelines. Saliva and dried blood spot tests can be useful in specific contexts, but for dosing core sex steroids, serum assays remain the most interpretable in my hands.
Compounded prescriptions are mapped to the person, not the diagnosis. For a woman with severe hot flashes and migraines with aura, I favor a very low transdermal estradiol cream, perhaps 0.02 mg nightly, topped up weekly until night sweats abate and migraines remain stable. For endometrial safety, I match that to micronized progesterone, often 100 mg at bedtime, or a compounded lower dose if sedation is too heavy, monitored with ultrasound if bleeding patterns are atypical.
For a man with confirmed low testosterone and a wish to maintain fertility, I discuss alternatives such as clomiphene or hCG before any exogenous testosterone. If TRT is the right path, I prefer to start with a modest dose. With compounded topicals, I might target 10 mg daily and adjust by 2 to 5 mg increments. With injections, accuracy is easier with approved sterile products, and I am conservative with compounded sterile preparations unless there is a compelling reason and a pharmacy with robust sterile process verification.
Setting expectations: timelines and trade-offs
The body rarely reads the memo on our timeline. Hot flashes can cool within days of a correct estradiol dose, but sleep architecture and mood often take 2 to 6 weeks to show steady change. Libido is notoriously multifactorial. Testosterone can boost sexual thoughts within days in men, but relationship dynamics, stress, and vaginal comfort in women often lag behind. Weight changes, if they come, reflect better sleep, more consistent training, improved insulin sensitivity, and sometimes a bump in basal metabolic rate, not magic fat melting.
Side effects are part of the conversation. Bloating, breast tenderness, and transient spotting show up when estrogen climbs. Anxiety, irritability, or a wired feeling can appear if testosterone overshoots or estradiol rises too fast. Acne and hair changes usually signal androgens that are too high. Dry Visit this page eyes and joint stiffness can surface if we oversuppress estrogen. The job is not to pretend these do not happen. It is to set a plan to detect them early and to course correct.
A practical monitoring cadence
The most reliable programs are boring in the best way. They reduce surprises and keep the patient in the loop.
- Before starting: document symptoms, collect baseline labs tailored to the case, review cancer screening status, and agree on goals that can be measured or described clearly. Early phase: reassess symptoms at 2 to 4 weeks, adjust dose in small increments, and check safety labs when indicated, such as hematocrit in men on TRT at 4 to 8 weeks if symptomatic. Stabilization: confirm labs once a dose holds steady for 6 to 8 weeks. For women on estrogen and progesterone, verify estradiol is in the intended range and bleeding patterns are appropriate. For men, track total and free testosterone, hematocrit, and lipids. Maintenance: follow visits every 3 to 6 months in the first year, then at least twice yearly, with labs at a frequency that reflects stability and risk profile. Red flags: unscheduled heavy bleeding after several months on therapy, hematocrit above target, blood pressure rises, new migraines with neurologic aura, or mood instability that is out of proportion to life context all trigger earlier review.
Real-world case sketches
A 48-year-old ER hormone therapy nurse with perimenopausal mood swings, sleep disruption, and plantar fasciitis came in exhausted. She had tried a standard estradiol patch but developed a rash that spread beyond the adhesive. We compounded a 0.02 mg per dose estradiol cream with a hypoallergenic base, plus 100 mg micronized progesterone at bedtime. At two weeks her night sweats had dropped from nine episodes to two. We raised estradiol to 0.03 mg nightly. At six weeks she was sleeping through most nights and had the patience to stretch after shifts, which eased her heel pain enough to resume short runs. The point is not that estradiol cures tendon trouble. It is that better sleep and thermoregulation gave her back bandwidth for the habits that heal.
A 57-year-old accountant with fatigue and low libido had morning total testosterone readings of 235 and 255 ng/dL, with normal prolactin and borderline-high BMI. After a frank discussion of expectations, we started a compounded testosterone cream at 12 mg daily, with sleep, nutrition, and resistance training goals. At week four he felt wired and irritable in the afternoon. Labs showed a free testosterone that had overshot. We reduced to 8 mg and split the dose morning and evening. At 10 weeks his energy had smoothed, hematocrit was steady, and he was down 8 pounds with three lifting sessions weekly. The key was not the cream, it was the size of the adjustment and the patience to titrate.
A 32-year-old trans woman initiating gender-affirming hormone therapy wanted a slower pace than the standard steps because of job considerations. We used low-dose transdermal estradiol, 0.0125 mg daily, and incremental increases every 6 to 8 weeks, with spironolactone introduced at a conservative dose. Compounded strengths made those small steps feasible without cutting patches. Her labs and physical changes moved in the intended direction, and the plan respected her preferences and life constraints.
Where compounding fits within broader options
Hormone therapy is an umbrella. It includes FDA-approved estradiol patches and gels, oral and vaginal estrogen, micronized progesterone capsules, synthetic progestins, testosterone injections and gels, DHEA therapy in selected cases, and thyroid hormone replacement for hypothyroidism. Out at the edges are growth hormone therapy and IGF-1 therapy, which require strict indications and careful risk discussion, and are not general wellness tools. There are also adrenal hormone discussions, where the real work is usually stress physiology and sleep, not cortisol treatment.
Within that umbrella, compounded hormone therapy is a scalpel, not a sledgehammer. It is particularly useful for:
- Dose gaps where standard increments are too coarse, especially at low or ultra-low starts. Allergen avoidance, such as dye-free, peanut oil-free, or adhesive-free needs. Combination therapy in a single application when adherence is a challenge. Uncommon routes, like vaginal progesterone for a patient intolerant of oral sedation. Gradual titration in gender-affirming care where life demands a slower tempo.
Common misconceptions worth clearing
“Bioidentical hormones are automatically safer.” Safer compared to what, and for whom? The molecule is the same as endogenous, but risk depends on route, dose, timing, and personal history. Transdermal estradiol is often safer for clot risk than oral forms, whether compounded or not. Progesterone protects the endometrium, but the dose and adherence matter more than the label “bioidentical.”
“Saliva tells me my perfect dose.” Salivary testing is useful for some hormones like cortisol in specific contexts. For estradiol, progesterone, and testosterone dosing, serum levels remain more reliable and interpretable in most clinical settings. I use symptom tracking in tandem with blood work and, when appropriate, ultrasound or other imaging.
“Pellets are easiest, so they must be best.” Ease is one variable. Irreversibility for months is another. If you dislike narrow guardrails, pellets may frustrate you. If consistency is your Achilles’ heel and you tolerate pellets well, they can be reasonable with conservative dosing and careful follow-up.
“Compounded means unregulated.” Compounding is regulated differently, not unregulated. Quality varies across pharmacies, which is why vetting matters. Accreditation, transparency, and consistency separate reliable partners from the pack.
The role of the team
An experienced hormone specialist is part clinician, part coach, and part detective. The nurse who returns your message about unexpected spotting at 9 pm, the pharmacist who flags an interaction, and the primary care clinician who keeps an eye on blood pressure and cancer screenings all guard the edges. I ask patients to bring their partner to early visits when possible, not to outsource decisions, but because small details at home often reveal dosing clues.
I also put boundaries around scope. I am comfortable managing menopause hormone therapy, perimenopause symptoms, low hormone treatment in men with documented deficiency, and many forms of integrative hormone therapy that sit within a functional medicine framework. I refer to endocrinology for complex pituitary disease, atypical lab constellations, or when endocrine tumors need evaluation. For transgender care, I collaborate with mental health professionals experienced in gender-affirming care and adhere to accepted protocols, customizing the pace without reinventing the guardrails.
What success looks like
Success rarely looks like a single perfect number. On paper, a man can move his total testosterone from 280 to 620 ng/dL and still feel flat if he is sleeping five hours and living on takeout. A woman can show an estradiol of 60 pg/mL and still have vaginal dryness if we forgot local therapy. A trans woman can hit target estradiol ranges and still feel out of sync if the social environment is hostile. Hormone optimization works best inside a broader plan that respects nutrition, movement, sleep, stress, and relationships.
In my charts, the signs of success are quieter. Fewer portal messages about sudden night sweats. A forgotten inhaler in a woman whose hot flashes were triggering asthma. A man who shows up to his maintenance visit describing a regular lifting program rather than a new dose request. A trans patient who chooses to hold a dose for another two months because the current pace fits her life right now. Those are mundane, and they are the point.
If you are considering compounded therapy
Start with the question, why do I need a compound instead of a standard option? If the answer is a specific tolerance issue, a dose gap, or a route that better fits your physiology, you are on solid ground. Choose a hormone clinic that explains trade-offs clearly, not one that promises a side-effect-free path. Ask which pharmacy they use and why. Clarify how often you will be seen, what labs will be ordered, and what symptoms trigger an earlier check-in. Expect to spend the first 8 to 12 weeks learning how your body responds, with small measured adjustments. If your clinician leaps two dose tiers at once or says labs are unnecessary, it is reasonable to ask for the rationale.
Compounded hormone therapy is a tool. Used judiciously by a hormone doctor who listens, with a patient who keeps notes and speaks up early, it can fill the gaps that keep many people hovering between too much and not enough. The promise is not perfection. It is a fit that respects your biology and your goals, one careful adjustment at a time.